Loading...

NewsRoom

Intas arm Accord, Myovant Sciences join hands to sell prostate cancer drug ...

Orgovyx to be used for treatment of advanced hormone-sensitive prostate cancer in Europe Intas Pharmaceuticals Ltd's arm, Accord ...
Read More

Indian pharma players line up for UK investments, partnerships...

After UK PM Boris Johnson's visit, major companies express expansion plans, tie-ups

The recently-concluded India visit ...
Read More

EU estimates up to 80% of population has had COVID

The European Commission said that between 60% and 80% of the EU population was estimated to have been infected with COVID-19, as t...
Read More

Pigments major Asahi Songwon Colors forays into API...

Pigments major Asahi Songwon Colours Limited announced its foray into the pharmaceutical manufacturing space with the acquisition ...
Read More

U.S. Drug Supply Is Even More Reliant on India Than Thought...

Amid the first Covid-19 lockdowns in 2020 and worries that critical drugs could run low, a 200-year-old nonprofit, little known ou...
Read More

Second booster shields elderly from COVID but protection wanes quickly - st...

A fourth dose of the Pfizer/BioNTech vaccine lowered rates of COVID-19 among the elderly but the protection against infection appe...
Read More

WHO suspends U.N. supply of Bharat Biotech's Covaxin vaccine for COVID-19...

The World Health Organization said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin...
Read More

Costs of going unvaccinated in America are mounting for workers and compani...

Nearly a year after COVID vaccines became freely available in the U.S., one fourth of American adults remain unvaccinated, and a...
Read More